We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule (319502)

ARTG ID 319502

ARTG Name

IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule

Product name

IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule

ARTG Date

15 December 2020

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

ciclosporin

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule, Seqirus Pty Ltd, CON-1038

23 November 2022

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 23 November 2022 until 23 November 2023.
IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule, Seqirus Pty Ltd, CON-1180

16 November 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 16 November 2023 until 30 November 2024.
IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule, Seqirus Pty Ltd, CON-1181

16 November 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 16 November 2023 until 30 September 2026.
IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule, Seqirus Pty Ltd, CON-924

13 April 2022

Section 14 consent

Consent to Supply while noncompliant with standards. The consent is effective from 13 April 2022 until batch 4Q36K-R is exhausted.
IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule, Seqirus Pty Ltd, CON-953

8 June 2022

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from the 8 June 2022 until 30 November 2022.